Clinical trials
Phase 3 Recurrence trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
59 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2015 | 4 |
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 2 |
| 2021 | 8 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 4 |
| 2025 | 8 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 17 |
| Unknown status | 14 |
| Completed | 12 |
| Active, not recruiting | 10 |
| Not yet recruiting | 4 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sun Yat-sen University | 4 |
| Novartis Pharmaceuticals | 3 |
| Pfizer | 3 |
| Amgen | 2 |
| BeiGene | 2 |
| Bristol-Myers Squibb | 2 |
| Celgene | 2 |
| Fudan University | 2 |
| Janssen Research & Development, LLC | 2 |
| Jiangsu HengRui Medicine Co., Ltd. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 59 |
| Multiple Myeloma | 12 |
| Carcinoma, Hepatocellular | 6 |
| Lymphoma, Large B-Cell, Diffuse | 3 |
| Nasopharyngeal Carcinoma | 3 |
| Neoplasms | 3 |
| Ovarian Neoplasms | 3 |
| Breast Neoplasms | 2 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Leukemia, Myeloid, Acute | 2 |
Trials
Showing 1 to 25 of 59. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.